This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House
 
Bank of America Names CEO Brian Moynihan as Chairman of Its Board

Bank of America has elected chief executive Brian Moynihan as chairman of its board.

U.S. Stocks Waver at the Opening Bell on ECB, Earnings & Initial Claims

Stocks started the day mixed with just the Nasdaq trading higher Thursday.

Constellation Brands & McCormick Earnings, Jim Cramer Swipes AmEx

As we get ready to ring out the second quarter of 2014's earnings season, it's time to toast one company that's managed to juice its top line -- Constellation Brands.

SAP Struggles Against its New Cloud Competitors: Chart of the Day

SAP AG has run into some problems, and it comes at a bad time for any Silicon Valley-based companies to run into trouble with shareholders.

Navigating United Continental, Delta, American, & the Volatility Play

Volatility is back in the picture for U.S. markets, and in a big way.

Real Money Previews

Real Money Pro's Doug Kass: Prying Into the Lagging Russell

What does small-cap weakness mean for the rest of the market?

Cramer on the Stock Market and Trading: How to Cut Your Losses

When a stock disappoints, you're better out of it.

Death Cross? Don't Abandon the Russell 2000 Index Just Yet

The small-cap stock index has fallen to 'death cross' territory but that might be changing soon.

Mad Money Recap

'Mad Money' Lightning Round: I'm Taking a Pass on New York Community Bancorp

Cramer likes Salix Pharmaceuticals but would like Lazard better at a 3% yield.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to find the stocks he and Stephanie Link think could be HUGE winners. Click here to see them for FREE.

Stock Ideas

How to Trade the Market's Most-Active Stocks: RFMD, AKS, TKMR, ANGI

Here's how to trade some of the most active stocks on the market right now.

3 Big Stocks on Traders' Radars: JCP, DAL, GSAT

Here's how to trade some of the most active stocks on the market right now.

5 Big-Volume Stocks to Trade for Big Breakouts

These stocks rising on unusual volume are within range of triggering breakout trades.

5 Stocks Spiking on Unusual Volume

Keep these stocks trading on unusual volume on your radar.

5 Stocks With Big Insider Buying

Insiders at these companies have been scooping up shares of their own stock lately.

MainStreet

It's Time to Set Aside a 4-Year Cash Cushion: Here's Why

Sometimes it’s not what you make but what you keep.

How to Handle An Unexpected Early Retirement By Being Proactive

Many Americans are faced with an unexpected early retirement and are forced into it by layoffs or health issues, disrupting their previous financial plans.

Senior Citizens Now Have $18.2 Billion in Student Loan Debt -- And Growing

When the topic of student loan debt is brought up, most people think of stressed out Millennials or Generation X-ers. However, the problem is also increasingly impacting older Americans.

How to Dispute Items on Your Credit Report and Win: Use This Strategy

As many as 40 million Americans have errors on their credit report. Unfortunately, once you find the errors, it’s hard to know how to go about removing them.

10 Questions a Career Coach Says Will Help You Ace Job Interviews

Any anxious job applicant fares worse than candidates who have a good grip on their nerves, who get more job offers and can even get more money.

Biotech

Why You Should Stay Away From the Ebola Frenzy in Biotech Stocks

Ebola lands in Texas, so expect some crazy volatility Wednesday in biotech and drug stocks.

Shkreli's Inability to Focus, Immaturity Cost Him Retrophin CEO Job

Martin is super smart and will be a great asset somewhere, but he is not a CEO. I wish him the best.

Why J&J Expands Antiviral Franchise but Doesn't Buy Achillion, Novavax

What are the motivations behind significant takeovers, like J&J's takeover of Alios Biopharma? And why have companies like Achillion and Novavax been passed over?

Beyond Wall St.

Deal News

Albemarle Stock Price Slide Creates Doubt for Rockwood Deal

Shares of the buyer have dropped about 20% since the deal was announced.

Babcock & Wilcox, With an Activist's Push, Studies Split

Blue Harbour Group had said the company should separate its power generation from its nuclear business.

MF Global Secured Creditors Made Whole in $295 Million Payout

Unsecured creditors will recover 20% of their claims from the initial distribution.

TheStreetTV
Spin Space

Jim Cramer

Cramer on the Stock Market and Trading: How to Cut Your Losses

When a stock disappoints, you're better out of it.

Herb Greenberg

Herb Greenberg: Too Soon to Question GoPro's Earnings Quality?

Keep these points from its most recent quarter in mind.

Stephanie Link

Jim Cramer Tells Stephanie Link Money Will Go to Secular Growth Trends

Consumer's money will go to places where there are secular growth trends, self-help and improvement says Jim Cramer.

Chris Ciaccia

How Elon Musk Continues to Pull Rabbits Out of a Hat, As Tesla Is Set to 'Unveil the D'

Tesla CEO Elon Musk continues to set the world ablaze, as the enigmatic leader unveiled that Tesla has more to show off than is currently known.

Adam Feuerstein

Why You Should Stay Away From the Ebola Frenzy in Biotech Stocks

Ebola lands in Texas, so expect some crazy volatility Wednesday in biotech and drug stocks.

Dan Freed

Why Fannie Mae and Freddie Mac Investors May Want to Wait to Sell

Fannie Mae and Freddie Mac investors dumped their holdings following an unfavorable legal decision. But some investment pros think it might be wiser to wait.

Ted Reed

Eyes on Delta as Airline Shares Face Correction, Ebola Scare

Delta, American, Southwest, JetBlue and Spirit shares all gave up more than 3% on Wednesday. Delta reports September unit revenue on Thursday.

Leon Lazaroff

TV Ratings Off to Bad Start Amid Surge in Digital Video

Television executives have downplayed the summer ratings slip, but the fall viewing season only reinforces the view that broadcast and pay-TV viewing is declining.

Submit an article to us!
DOW 16,795.62 -9.09 -0.05%
S&P 500 1,946.64 +0.48 0.02%
NASDAQ 4,426.1210 +4.0360 0.09%

Brokerage Partners

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs